Literature DB >> 25688757

Functional GIP receptors play a major role in islet compensatory response to high fat feeding in mice.

R Charlotte Moffett1, Srividya Vasu2, Peter R Flatt2.   

Abstract

BACKGROUND: Consumption of high fat diet and insulin resistance induce significant changes in pancreatic islet morphology and function essential for maintenance of normal glucose homeostasis. We have used incretin receptor null mice to evaluate the role of gastric inhibitory polypeptide (GIP) in this adaptive response.
METHODS: C57BL/6 and GIPRKO mice were fed high fat diet for 45 weeks from weaning. Changes of pancreatic islet morphology were assessed by immunohistochemistry. Body fat, glucose, insulin, glucagon, glucagon-like peptide 1 (GLP-1) and GIP were assessed by routine assays.
RESULTS: Compared with normal diet controls, high fat fed C57BL/6 mice exhibited increased body fat, hyperinsulinaemia and insulin resistance, associated with decreased pancreatic glucagon, unchanged pancreatic GLP-1 and marked increases of insulin, islet number, islet size and both beta- and alpha-cell areas. Beta cell proliferation and apoptosis were increased under high fat feeding, but the overall effect favoured enhanced beta cell mass. A broadly similar pattern of change was observed in high fat fed GIPRKO mice but islet compensation was severely impaired in every respect. The inability to enhance beta cell proliferation was associated with the depletion of pancreatic GLP-1 and lack of hyperinsulinaemic response, resulting in non-fasting hyperglycaemia. GIP and GLP-1 were expressed in islets of all groups of mice but high fat fed GIPRKO mice displayed decreased numbers of GLP-1 containing alpha cells plus non-functional enhancement of pancreatic GIP content. GENERAL SIGNIFICANCE: These data suggest that GIP released from islet alpha-cells and intestinal K-cells plays an important role in islet adaptations to high fat feeding.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alpha-cell; Gastric inhibitory polypeptide; Immunohistochemistry; K-cell

Mesh:

Substances:

Year:  2015        PMID: 25688757     DOI: 10.1016/j.bbagen.2015.02.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

Review 1.  New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders.

Authors:  Nigel Irwin; Peter R Flatt
Journal:  World J Diabetes       Date:  2015-11-10

2.  Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic GluCreERT2;ROSA26-eYFP mice.

Authors:  Dipak Sarnobat; R Charlotte Moffett; Victor A Gault; Neil Tanday; Frank Reimann; Fiona M Gribble; Peter R Flatt; Nigel Irwin
Journal:  Peptides       Date:  2019-11-16       Impact factor: 3.750

3.  Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin.

Authors:  Atsushi Iida; Yusuke Seino; Ayako Fukami; Ryuya Maekawa; Daisuke Yabe; Shinobu Shimizu; Keita Kinoshita; Yusuke Takagi; Takako Izumoto; Hidetada Ogata; Kota Ishikawa; Nobuaki Ozaki; Shin Tsunekawa; Yoji Hamada; Yutaka Oiso; Hiroshi Arima; Yoshitaka Hayashi
Journal:  Diabetologia       Date:  2016-04-06       Impact factor: 10.122

4.  Noninvasive Evaluation of GIP Effects on β-Cell Mass Under High-Fat Diet.

Authors:  Sakura Kiyobayashi; Takaaki Murakami; Norio Harada; Hiroyuki Fujimoto; Yuki Murata; Naotaka Fujita; Keita Hamamatsu; Eri Ikeguchi-Ogura; Tomonobu Hatoko; Xuejing Lu; Shunsuke Yamane; Nobuya Inagaki
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-12       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.